ALEMBICLTD · NSE
Not in active coverage. Cited reporting has mentioned Alembic, the record of those mentions is below. Your interest is logged; coverage expands by demand.
Alembic Pharmaceuticals announced that the US Food and Drug Administration (USFDA) issued an Establishment Inspection Report (EIR) and communicated the closure of its inspection at the company's Bioequivalence Facility in Vadodara, Gujarat.
Alembic Pharmaceuticals announced that the USFDA completed an inspection at its bioequivalence facility in Vadodara, Gujarat, with zero observations.
This page lists where cited reporting has mentioned Alembic. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.